<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The transcription of two early "leftwardly" expressed genes carrying repetitive sequences, IR2 and IR4, has been studied for Epstein-Barr virus-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, and for established B-cell lines, using sequence-specific probes generated for this purpose </plain></SENT>
<SENT sid="1" pm="."><plain>Whereas the IR4 transcript was identified in every <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and cell line assessed (except B95-8, with a deletion that removes the gene), expression of the IR2 gene was restricted to B lymphocytes </plain></SENT>
<SENT sid="2" pm="."><plain>Though the promoters for both transcripts lie within homologous regions (D(L) and D(R)) in the <z:mp ids='MP_0001799'>viral</z:mp> genome, the IR2 promoter appears more tightly regulated </plain></SENT>
<SENT sid="3" pm="."><plain>Detailed characterization of the IR4 transcript from a nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, C15, identifies a sequence variant of this gene that differs from those reported for B cells; in situ hybridization methods show transcription to be restricted to a subset of cells, with the strongest signals seen adjacent to host stroma </plain></SENT>
<SENT sid="4" pm="."><plain>As with B cells in culture (Y </plain></SENT>
<SENT sid="5" pm="."><plain>Gao, P </plain></SENT>
<SENT sid="6" pm="."><plain>R </plain></SENT>
<SENT sid="7" pm="."><plain>Smith, L </plain></SENT>
<SENT sid="8" pm="."><plain>Karran, Q </plain></SENT>
<SENT sid="9" pm="."><plain>L </plain></SENT>
<SENT sid="10" pm="."><plain>Lu, and B </plain></SENT>
<SENT sid="11" pm="."><plain>E </plain></SENT>
<SENT sid="12" pm="."><plain>Griffin, J </plain></SENT>
<SENT sid="13" pm="."><plain>Virol </plain></SENT>
<SENT sid="14" pm="."><plain>71:84-94, 1997), chemical induction enhanced transcriptional expression of the IR4 gene in the C15 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, although staining for both the IR4 antigen and that of the virus lytic switch, Zta, gave negative results </plain></SENT>
<SENT sid="15" pm="."><plain>In a Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> biopsy specimen, however, both proteins were found expressed, notably in the same subset of cells </plain></SENT>
<SENT sid="16" pm="."><plain>The data here and elsewhere (Gao et al., J </plain></SENT>
<SENT sid="17" pm="."><plain>Virol., 1997) are consistent with a block to intracellular transport of the transcript(s) and suggest nuclear roles for it in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, possibly in <z:chebi fb="40" ids="33697">RNA</z:chebi> processing and <z:mp ids='MP_0001799'>viral</z:mp> lytic replication </plain></SENT>
<SENT sid="18" pm="."><plain>Both roles could be fulfilled in the absence of translation </plain></SENT>
</text></document>